Naxitamab clinical trials

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

This study is testing a new medicine called Naxitamab for children and young people recently diagnosed with a serious type of cancer called high-risk neuroblastoma. It's given alongside their usual chemotherapy to see if it helps treatment work better and improves their chances of recovery.